Clinical Trial Update: Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial [Phase 3]

View source ↗

Summary

This update describes a Phase 3 randomized controlled trial of collagen crosslinking for keratoconus, with the trial currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Keratoconus | Phase 3 | Status: ACTIVE_NOT_RECRUITING